Levels of Tobacco-specific Metabolites among Non-smoking Lung Cancer Cases at Diagnosis: Case-control Findings |
Hwang, Sang-Hyun
(Department of Laboratory Medicine, Center for Diagnostic Oncology)
Ryu, Hye-Jung (Department of Laboratory Medicine, Center for Diagnostic Oncology) Kang, Soo Jin (Department of Laboratory Medicine, Center for Diagnostic Oncology) Yun, E. Hwa (Branch of Cancer Risk Appraisal and Prevention, National Cancer Information Center, National Cancer Control Institute, National Cancer Center) Lim, Min Kyung (Branch of Cancer Risk Appraisal and Prevention, National Cancer Information Center, National Cancer Control Institute, National Cancer Center) Kim, Heung Tae (Center for Lung Cancer, National Cancer Center Hospital) Lee, Jin Soo (Center for Lung Cancer, National Cancer Center Hospital) Lee, Do-Hoon (Department of Laboratory Medicine, Center for Diagnostic Oncology) |
1 | Anderson KE, Carmella SG, Ye M, et al (2001). Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. J Natl Cancer Inst, 93, 378-81. DOI ScienceOn |
2 | Bernert JT, Pirkle JL, Xia Y, et al (2010). Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U.S. population from secondhand smoke exposure. Cancer Epidemiol Biomarkers Prev, 19, 2969-77. DOI ScienceOn |
3 | Brennan P, Buffler PA, Reynolds P, et al (2004). Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies. Int J Cancer, 109, 125-31. DOI ScienceOn |
4 | Church TR, Anderson KE, Caporaso NE, et al (2009). A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev, 18, 260-6. DOI ScienceOn |
5 | Couraud S, Zalcman G, Milleron, B, et al (2012). Lung cancer in never smokers - a review. Eur J Cancer, 48, 1299-311. DOI ScienceOn |
6 | Florescu A, Ferrence R, Einarson T, et al (2009). Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit, 31, 14-30. DOI ScienceOn |
7 | Hashimoto K, Ohsawa K, Kimura M (2004). Mutations induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the lacZ and cII genes of Muta Mouse. Mutat Res, 560, 119-31. DOI ScienceOn |
8 | Hecht SS (2004). Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke. Tob Control, 1, 48-56. |
9 | Hecht SS (2006). A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder's opinion about ETS and lung cancer. Prev Med, 43, 256-60. DOI ScienceOn |
10 | Hecht SS, Ye M, Carmella SG, Fredrickson A, et al (2001). Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol Biomarkers Prev, 10, 1109-16. |
11 | Jacob P, Havel C, Lee DH, Yu L, Eisner MD, et al (2008). Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem, 80, 8115-21. DOI ScienceOn |
12 | Kamsa-Ard S, Promthet S, Lewington S, et al (2013). Association between smoking and mortality: Khon Kaen cohort study, Thailand. Asian Pac J Cancer Prev, 14, 2643-7. DOI ScienceOn |
13 | Lackmann GM, Salzberger U, Tollner U, et al (1999). Metabolites of a tobacco-specific carcinogen in urine from newborns. J Natl Cancer Inst, 91, 459-65. DOI ScienceOn |
14 | Park S, Bae J, Nam BH, et al (2008). Aetiology of cancer in Asia. Asian Pac J Cancer Prev, 9, 371-80. |
15 | Parsons WD, Carmella SG, Akerkar S, et al (1998). A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiol Biomarkers Prev, 7, 257-60. |
16 | Sisti J, Boffetta P (2012). What proportion of lung cancer in never-smokers can be attributed to known risk factors? Int J Cancer, 131, 265-75. DOI ScienceOn |
17 | Yuan JM, Gao YT, Murphy SE, et al (2012). Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res, 71, 6749-57. |
18 | Yano T, Haro A, Shikada Y, Maruyama R, et al (2011). Non-small cell lung cancer in never smokers as a representative ‘non-smoking-associated lung cancer’: epidemiology and clinical features. Int J Clin Oncol, 16, 287-93. DOI |
![]() |